Roche to acquire Carmot Therapeutics to expand obesity treatment portfolio
Roche announced its definitive agreement to acquire Carmot Therapeutics, Inc., based in Berkeley, California, for an upfront purchase price of USD 2.7 billion, with additional milestone payments of up to USD 400 million. Carmot Therapeutics’ Incretin Portfolio: A Boon for Obesity Treatment The acquisition provides Roche access to Carmot Therapeutics’ innovative portfolio of incretins, which […]